Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Primary Dysautonomias × Bloodletting × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Primary Dysautonomias 1 Polycystic Ovary Syndrome 1 Metabolic Syndrome 1 Insulin Resistance 1 Hyperandrogenism 1

Interventions

enzalutamide 1 bicalutamide 1 Receptors, Androgen 1 Phlebotomy 1 Leuprolide 1 High-Intensity Interval Training 1 Goserelin 1 Flutamide 1 Exercise 1 Ethinyl Estradiol 1 Cyproterone Acetate 1 Bloodletting 1 Blood Donation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02460445 2022-07-27

Phlebotomy and Polycystic Ovary Syndrome

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Phase NA Completed

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome, Primary Dysautonomias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡